Immunotherapy and niche biotech companies battle rare cancers
People in Kentucky with rare forms of cancer often face limited options for treatment. The rarity of their diseases limits the number of patients that scientists can study. The low numbers of patients mean that fewer researchers focus on their diseases, and little...
